|
MPHOSPH10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.239000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.024200E-03 |
| Normal-vs-Stage2 |
5.808300E-02 |
| Normal-vs-Stage3 |
6.995700E-02 |
| Normal-vs-Stage4 |
1.142030E-02 |
| Stage1-vs-Stage2 |
6.471000E-01 |
| Stage1-vs-Stage3 |
5.035600E-01 |
| Stage1-vs-Stage4 |
3.388600E-01 |
| Stage2-vs-Stage3 |
4.351800E-01 |
| Stage2-vs-Stage4 |
7.655800E-01 |
| Stage3-vs-Stage4 |
2.002400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.537600E-03 |
| Normal-vs-AfricanAmerican |
1.318350E-02 |
| Normal-vs-Asian |
1.191370E-01 |
| Caucasian-vs-AfricanAmerican |
5.170000E-01 |
| Caucasian-vs-Asian |
7.103000E-01 |
| AfricanAmerican-vs-Asian |
8.995800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.943800E-02 |
| Normal-vs-Female |
1.183720E-04 |
| Male-vs-Female |
6.825000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.826000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.099400E-03 |
| Normal-vs-Age(61-80Yrs) |
7.319700E-03 |
| Normal-vs-Age(81-100Yrs) |
6.769400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.448400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.105400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.341400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.043600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.297820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.875800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.738600E-03 |
| Normal-vs-Grade 2 |
1.633450E-04 |
| Normal-vs-Grade 3 |
1.267200E-01 |
| Normal-vs-Grade 4 |
3.058200E-02 |
| Grade 1-vs-Grade 2 |
3.664400E-01 |
| Grade 1-vs-Grade 3 |
9.586200E-02 |
| Grade 1-vs-Grade 4 |
4.199600E-02 |
| Grade 2-vs-Grade 3 |
1.735710E-02 |
| Grade 2-vs-Grade 4 |
1.189200E-01 |
| Grade 3-vs-Grade 4 |
4.747200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.89230000002816E-06 |
| Normal-vs-ccB subtype |
8.431000E-01 |
| ccA subtype-vs-ccB subtype |
1.96609999947306E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.782100E-02 |
| Normal-vs-N1 |
2.291600E-01 |
| N0-vs-N1 |
9.118000E-01 |
|
|
